Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Novel approaches to antiviral and anticancer immunotherapy.

Trnkov√° K, Pastorekov√° S, Petrik J.

Acta Virol. 2012;56(4):271-82. Review.

PMID:
23237083
2.

Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.

Khawli LA, Hu P, Epstein AL.

Handb Exp Pharmacol. 2008;(181):291-328. Review.

PMID:
18071951
3.

Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.

Bodey B, Siegel SE, Kaiser HE.

Anticancer Res. 1996 Mar-Apr;16(2):661-74. Review.

PMID:
8687112
4.

The role of antigen-specific and non-specific immunotherapy in the treatment of cancer.

Monjazeb AM, Hsiao HH, Sckisel GD, Murphy WJ.

J Immunotoxicol. 2012 Jul-Sep;9(3):248-58. doi: 10.3109/1547691X.2012.685527. Epub 2012 Jun 26. Review.

PMID:
22734880
5.

Prospects and limitations of recombinant poxviruses for prostate cancer immunotherapy.

Hwang C, Sanda MG.

Curr Opin Mol Ther. 1999 Aug;1(4):471-9. Review.

PMID:
11713762
6.

T-cell-receptor-like antibodies - generation, function and applications.

Dahan R, Reiter Y.

Expert Rev Mol Med. 2012 Feb 24;14:e6. doi: 10.1017/erm.2012.2. Review.

PMID:
22361332
7.

New perspectives in glioma immunotherapy.

Daga A, Bottino C, Castriconi R, Gangemi R, Ferrini S.

Curr Pharm Des. 2011;17(23):2439-67. Review.

PMID:
21827420
8.

Tumor antigen-specific T helper cells in cancer immunity and immunotherapy.

Knutson KL, Disis ML.

Cancer Immunol Immunother. 2005 Aug;54(8):721-8. Epub 2005 Jan 27. Review.

PMID:
16010587
9.

Molecularly defined vaccines for cancer immunotherapy, and protective T cell immunity.

Speiser DE, Romero P.

Semin Immunol. 2010 Jun;22(3):144-54. doi: 10.1016/j.smim.2010.03.004. Epub 2010 Apr 21. Review.

PMID:
20413326
10.

[Immunotherapy in virus diseases].

Schulte-Wissermann H, Schofer O.

Monatsschr Kinderheilkd. 1986 Apr;134(4):172-81. German.

PMID:
2422548
11.

Tumor vaccine: current trends in antigen specific immunotherapy.

Baral R.

Indian J Exp Biol. 2005 May;43(5):389-406. Review.

PMID:
15900903
12.

Intratumoral immunotherapy: using the tumour against itself.

Crittenden MR, Thanarajasingam U, Vile RG, Gough MJ.

Immunology. 2005 Jan;114(1):11-22. Review.

13.

Immunotherapy II: Antigens, receptors and costimulation.

Searle PF, Young LS.

Cancer Metastasis Rev. 1996 Sep;15(3):329-49. Review.

PMID:
9034595
14.

Tumor antigen-based immunotherapy and immunoprevention of cancer.

Ryan SO, Gantt KR, Finn OJ.

Int Arch Allergy Immunol. 2007;142(3):179-89. Epub 2006 Nov 13. Review.

15.

Immunotherapy for persistent viral infections and associated disease.

van der Burg SH, Arens R, Melief CJ.

Trends Immunol. 2011 Mar;32(3):97-103. doi: 10.1016/j.it.2010.12.006. Epub 2011 Jan 10.

PMID:
21227751
16.

Antitumor vaccination: where we stand.

Bocchia M, Bronte V, Colombo MP, De Vincentiis A, Di Nicola M, Forni G, Lanata L, Lemoli RM, Massaia M, Rondelli D, Zanon P, Tura S.

Haematologica. 2000 Nov;85(11):1172-206. Review.

17.

Combination strategies for enhancing the efficacy of immunotherapy in cancer patients.

Moschella F, Proietti E, Capone I, Belardelli F.

Ann N Y Acad Sci. 2010 Apr;1194:169-78. doi: 10.1111/j.1749-6632.2010.05464.x. Review.

PMID:
20536466
18.

Using antibodies in tumour immunotherapy.

Schultes BC, Nicodemus CF.

Expert Opin Biol Ther. 2004 Aug;4(8):1265-84. Review.

PMID:
15268661
19.
20.

What's new in the field of cancer vaccines?

Renno T, Lebecque S, Renard N, Saeland S, Vicari A.

Cell Mol Life Sci. 2003 Jul;60(7):1296-310. Review.

PMID:
12943219

Supplemental Content

Support Center